Abstract
After radical prostatectomy 20% to 40% of patients have detectable prostate-specific antigen (PSA), indicating the potential presence of residual
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
